Selected article for: "outcome improve and respiratory virus"
Author: Miranda-Zazueta, G.; González-Regueiro, J. A.; García-Juárez, I.; Moctezuma-Velázquez, C.; López-Díaz, F. J.; Pérez-González, B.; Uscanga-Domínguez, L. F.; Peláez-Luna, M.
Title: Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic
  • Cord-id: 9egu331t
  • Document date: 2020_9_30
    • ID: 9egu331t
    Snippet: The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. COVID-19 affected close to 2 million persons worldwide in fewer than 4 months, after the report of the first cases in China in December 2019. The relation of the disease caused by SARS-Cov-2 to immunosuppressive treatment used in different gastrointestinal disorders is uncertain, resulting in debate with regard to suspending immunosuppressive therapy to improve infection o
    Document: The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. COVID-19 affected close to 2 million persons worldwide in fewer than 4 months, after the report of the first cases in China in December 2019. The relation of the disease caused by SARS-Cov-2 to immunosuppressive treatment used in different gastrointestinal disorders is uncertain, resulting in debate with regard to suspending immunosuppressive therapy to improve infection outcome. Said suspension implies the inherent risk for graft rejection or autoimmune disease exacerbation that can potentially worsen the course of the infection. Based on the presently available evidence, a treatment stance has been established for patients with gastrointestinal diseases that require immunosuppressive therapy.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and acute pancreatitis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
    • abdominal pain and acute pancreatitis present: 1, 2, 3, 4
    • abdominal pain and admission rate: 1, 2, 3, 4, 5
    • abdominal pain and adrenal insufficiency: 1, 2, 3, 4, 5
    • abdominal pain and liver biopsy: 1, 2, 3, 4
    • abdominal pain and liver cirrhosis: 1, 2, 3
    • abdominal pain and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
    • abdominal pain and liver diseases: 1, 2, 3, 4, 5, 6
    • abdominal pain and liver failure: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • abdominal pain and liver function test: 1
    • abdominal pain and liver transplant: 1, 2, 3, 4
    • abdominal pain and liver transplantation: 1, 2, 3, 4, 5, 6, 7
    • abdominal pain and low quality: 1, 2, 3
    • abdominal pain and low respiratory: 1, 2, 3, 4, 5, 6
    • abdominal pain and low respiratory tract: 1
    • abdominal pain and low steroid: 1
    • abdominal pain and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • abdominal pain diarrhea and acute case: 1, 2, 3, 4